PTIX · Protagenic Therapeutics
Protagenic Therapeutics, Inc. operates as a pharmaceutical company specializing in the development of medicines manufactured from cannabinoid and cannabinoid-like molecules. The company was founded in 2004 and is based in New York, New York.
Market Cap
1.394M
52 Wk Range
$0.13 - $3.77
Previous Close
$0.77
Open
$0.77
Volume
227
Day Range
$0.77 - $0.77
Enterprise Value
3.34M
Cash
2.213M
Avg Qtr Burn
-509.7K
Insider Ownership
6.20%
Institutional Own.
3.69%
Qtr Updated
Dec 31st 2025